Background and Aims: Interleukin-11 (IL-11) is a stromal cell derived cytokine, highly expressed by smooth
muscle cells (SMCs), heart, skin and testis. Beyond its known role in stimulating
the maturation of megakaryocytes, it also exerts anti-inflammatory effects in T-cells
and macrophages. Our preliminary observations indicated that both high-density lipoproteins
(HDL) and sphingosine 1-phosphate (S1P) dose dependently induce IL-11 production in
SMCs, via S1P2 receptor stimulation. Since HDL-S1P showed anti-atherogenic potential,
we investigated the effects of exogenous administration of IL-11 to athero-prone mouse
models and in vitro.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to AtherosclerosisAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Publication history
Published online: August 05, 2019
EAS19-1121Identification
Copyright
© 2019 Published by Elsevier Inc.
